Adult mice lacking the type 2 iodothyronine deiodinase have increased subchondral bone but normal articular cartilage

Thyroid

Volumn 25, Issue 3, 2015, Pages 269-277

  Waung, Julian A ^a   Bassett, J H Duncan ^a   Williams, Graham R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE PRECURSOR; IODOTHYRONINE; LIOTHYRONINE; THYROXINE; THYROXINE DEIODINASE; TYPE 1 IODOTHYRONINE DEIODINASE; TYPE 2 IODOTHYRONINE DEIODINASE; UNCLASSIFIED DRUG; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE; BONE EROSION; BONE MINERAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIGITAL RADIOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE IDENTIFICATION; GENOTYPE; HISTOPATHOLOGY; KNEE; MICRORADIOGRAPHY; MOUSE; NONHUMAN; OSTEOARTHRITIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCHONDRAL BONE; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; EMBRYONIC STEM CELL; GENETICS; JOINT; KNOCKOUT MOUSE; MALE; METABOLISM; PHENOTYPE; PHYSIOLOGY;

ANIMALS; BONE AND BONES; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GENOTYPE; IODIDE PEROXIDASE; JOINTS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOARTHRITIS; PHENOTYPE; TRIIODOTHYRONINE;

EID: 84924415334     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0476     Document Type: Article

References (58)

1. Arden N, Nevitt MC 2006 Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 20:3-25
2. Lories RJ, Luyten FP 2011 The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 7:43-49
3. Burr DB, Gallant MA 2012 Bone remodelling in osteoarthritis. Nat Rev Rheumatol 8:665-673
4. Reynard LN, Loughlin J 2013 Insights from human genetic studies into the pathways involved in osteoarthritis. Nat Rev Rheumatol 9:573-583
5. Meulenbelt I, Bos SD, Chapman K, Van Der Breggen R, Houwing-Duistermaat JJ, Kremer D, Kloppenburg M, Carr A, Tsezou A, Gonzalez A, Loughlin J, Slagboom PE 2011 Meta-Analyses of genes modulating intracellular T3 bioavailability reveal a possible role for the DIO3 gene in osteoarthritis susceptibility. Ann Rheum Dis 70:164-167
6. Meulenbelt I, Min JL, Bos S, Riyazi N, Houwing-Duistermaat JJ, Van Der Wijk HJ, Kroon HM, Nakajima M, Ikegawa S, Uitterlinden AG, Van Meurs JB, Van Der Deure WM, Visser TJ, Seymour AB, Lakenberg N, Van Der Breggen R, Kremer D, Van Duijn CM, Kloppenburg M, Loughlin J, Slagboom PE 2008 Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet 17:1867-1875
7. Loughlin J 2011 Osteoarthritis year 2010 in review: genetics. Osteoarthritis Cartilage 19:342-345
8. Bos SD, Slagboom PE, Meulenbelt I 2008 New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr Opinion Rheum 20:553-559
9. Goldring MB 2013 Insight into the function of DIO2, a susceptibility gene in human osteoarthritis, as an inducer of cartilage damage in a rat model: is there a role for chondrocyte hypertrophy?. Osteoarthritis Cartilage 21:643-645
10. Williams AJ, Robson H, Kester MH, Van Leeuwen JP, Shalet SM, Visser TJ, Williams GR 2008 Iodothyronine deiodinase enzyme activities in bone. Bone 43:126-134
11. Cheng SY, Leonard JL, Davis PJ 2010 Molecular aspects of thyroid hormone actions. Endocr Rev 31:139-170
12. Galton VA, Schneider MJ, Clark AS, St Germain DL 2009 Life without thyroxine to 3, 5, 3¢-triiodothyronine conversion: studies in mice devoid of the 5¢-deiodinases. Endocrinology 150:2957-2963
13. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A, Bianco AC 2008 Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29:898-938
14. Nagase H, Nagasawa Y, Tachida Y, Sakakibara S, Okutsu J, Suematsu N, Arita S, Shimada K 2013 Deiodinase 2 upregulation demonstrated in osteoarthritis patients cartilage causes cartilage destruction in tissue-specific transgenic rats. Osteoarthritis Cartilage 21:514-523
15. Waung JA, Bassett JH, Williams GR 2012 Thyroid hormone metabolism in skeletal development and adult bone maintenance. Trends Endocrinol Metab 23:155-162
16. Dreier R 2010 Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Res Ther 12:216
17. Lin AC, Seeto BL, Bartoszko JM, Khoury MA, Whetstone H, Ho L, Hsu C, Ali SA, Alman BA 2009 Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15:1421-1425
18. Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, Flannery CR, Peluso D, Kanki K, Yang Z, Majumdar MK, Morris EA 2005 Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434:644-648
19. Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK, Fourie AM, Fosang AJ 2005 ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434:648-652
20. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR 1997 Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99:1534-1545
21. Chen-An P, Andreassen KV, Henriksen K, Karsdal MA, Bay-Jensen AC 2013 Investigation of chondrocyte hypertrophy and cartilage calcification in a full-depth articular cartilage explants model. Rheumatol Int 33:401-411
22. Himeno M, Enomoto H, Liu W, Ishizeki K, Nomura S, Kitamura Y, Komori T 2002 Impaired vascular invasion of Cbfa1-deficient cartilage engrafted in the spleen. J Bone Miner Res 17:1297-1305
23. Makihira S, Yan W, Murakami H, Furukawa M, Kawai T, Nikawa H, Yoshida E, Hamada T, Okada Y, Kato Y 2003 Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage. Endocrinology 144:2480-2488
24. Pereira RC, Jorgetti V, Canalis E 1999 Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am J Physiol 277:E496-504
25. Robson H, Siebler T, Stevens DA, Shalet SM, Williams GR 2000 Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 141:3887-3897
26. Kerkhof HJ, Lories RJ, Meulenbelt I, Jonsdottir I, Valdes AM, Arp P, Ingvarsson T, Jhamai M, Jonsson H, Stolk L, Thorleifsson G, Zhai G, Zhang F, Zhu Y, Van Der Breggen R, Carr A, Doherty M, Doherty S, Felson DT, Gonzalez A, Halldorsson BV, Hart DJ, Hauksson VB, Hofman A, Ioannidis JP, Kloppenburg M, Lane NE, Loughlin J, Luyten FP, Nevitt MC, Parimi N, Pols HA, Rivadeneira F, Slagboom EP, Styrkarsdottir U, Tsezou A, Van De Putte T, Zmuda J, Spector TD, Stefansson K, Uitterlinden AG, Van Meurs JB 2010A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum 62:499-510
27. Evangelou E, Kerkhof HJ, Styrkarsdottir U, Ntzani EE, Bos SD, Esko T, Evans DS, Metrustry S, Panoutsopoulou K, Ramos YF, Thorleifsson G, Tsilidis KK, Arden N, Aslam N, Bellamy N, Birrell F, Blanco FJ, Carr A, Chapman K, Day-Williams AG, Deloukas P, Doherty M, Engstrom G, Helgadottir HT, Hofman A, Ingvarsson T, Jonsson H, Keis A, Keurentjes JC, Kloppenburg M, Lind PA, McCaskie A, Martin NG, Milani L, Montgomery GW, Nelissen RG, Nevitt MC, Nilsson PM, Ollier WE, Parimi N, Rai A, Ralston SH, Reed MR, Riancho JA, Rivadeneira F, Rodriguez-Fontenla C, Southam L, Thorsteinsdottir U, Tsezou A, Wallis GA, Wilkinson JM, Gonzalez A, Lane NE, Lohmander LS, Loughlin J, Metspalu A, Uitterlinden AG, Jonsdottir I, Stefansson K, Slagboom PE, Zeggini E, Meulenbelt I, Ioannidis JP, Spector TD, Van Meurs JB, Valdes AM 2014A meta-Analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip. Ann Rheum Dis 73:2130-2136
28. Bos SD, Bovee JV, Duijnisveld BJ, Raine EV, Van Dalen WJ, Ramos YF, Van Der Breggen R, Nelissen RG, Slagboom PE, Loughlin J, Meulenbelt I 2012 Increased type II deiodinase protein in OA-Affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann Rheum Dis 71:1254-1258
29. Bomer N, den Hollander W, Ramos YF, Bos SD, Van Der Breggen R, Lakenberg N, Pepers BA, Van Eeden AE, Darvishan A, Tobi EW, Duijnisveld BJ, Van den Akker EB, Heijmans BT, Van Roon-Mom WM, Verbeek FJ, Van Osch GJ, Nelissen RG, Slagboom PE, Meulenbelt I 2014 Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis. Ann Rheum Dis [Epub ahead of print]; DOI: 10.1136/annrheumdis-2013-204739
30. Waarsing JH, Kloppenburg M, Slagboom PE, Kroon HM, Houwing-Duistermaat JJ, Weinans H, Meulenbelt I 2011 Osteoarthritis susceptibility genes influence the association between hip morphology and osteoarthritis. Arthritis Rheum 63:1349-1354
31. Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, Weedon MN, Singleton A, Hernandez D, Evans J, Durant C, Ferrucci L, Melzer D, Saravanan P, Visser TJ, Ceresini G, Hattersley AT, Vaidya B, Dayan CM, Frayling TM 2008A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab 93:3075-3081
32. Schneider MJ, Fiering SN, Thai B, Wu SY, St Germain E, Parlow AF, St Germain DL, Galton VA 2006 Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147:580-589
33. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, Galton VA 2001 Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15:2137-2148
34. Bassett JH, Boyde A, Howell PG, Bassett RH, Galliford TM, Archanco M, Evans H, Lawson MA, Croucher P, St Germain DL, Galton VA, Williams GR 2010 Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci U S A 107:7604-7609
35. Glasson SS, Chambers MG, Van Den Berg WB, Little CB 2010 The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 18:S17-23
36. Sondergaard BC, Catala-Lehnen P, Huebner AK, Bay-Jensen AC, Schinke T, Henriksen K, Schilling S, Haberland M, Nielsen RH, Amling M, Karsdal MA 2012 Mice overexpressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus. Osteoarthritis Cartilage 20:136-143
37. Hoegh-Andersen P, Tanko LB, Andersen TL, Lundberg CV, Mo JA, Heegaard AM, Delaisse JM, Christgau S 2004 Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther 6:R169-180
38. Waung JA, Maynard SA, Gopal S, Gogakos A, Logan JG, Williams GR, Bassett JH 2014 Quantitative X-ray microradiography for high-throughput phenotyping of osteoarthritis in mice. Osteoarthritis Cartilage 22:1396-1400
39. Bassett JH, Van Der Spek A, Gogakos A, Williams GR 2012 Quantitative X-ray imaging of rodent bone by Faxitron. Methods Mol Biol 816:499-506
40. Burr DB, Schaffler MB 1997 The involvement of subchondral mineralized tissues in osteoarthrosis: quantitative microscopic evidence. Microsc Res Tech 37:343-357
41. Van Der Kraan PM, Van den Berg WB 2012 Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?. Osteoarthritis Cartilage 20:223-232
42. Hayami T, Zhuo Y, Wesolowski GA, Pickarski M, Duong le T 2012 Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone 50:1250-1259
43. Orth P, Cucchiarini M, Wagenpfeil S, Menger MD, Madry H 2014 PTH [1-34]-induced alterations of the subchondral bone provoke early osteoarthritis. Osteoarthritis Cartilage 22:813-821
44. Dentice M, Bandyopadhyay A, Gereben B, Callebaut I, Christoffolete MA, Kim BW, Nissim S, Mornon JP, Zavacki AM, Zeold A, Capelo LP, Curcio-Morelli C, Ribeiro R, Harney JW, Tabin CJ, Bianco AC 2005 The Hedgehoginducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat Cell Biol 7:698-705
45. Carvalho-Bianco SD, Kim BW, Zhang JX, Harney JW, Ribeiro RS, Gereben B, Bianco AC, Mende U, Larsen PR 2004 Chronic cardiac-specific thyrotoxicosis increases myocardial beta-Adrenergic responsiveness. Mol Endocrinol 18:1840-1849
46. Cheng AW, Bolognesi M, Kraus VB 2012 DIO2 modifies inflammatory responses in chondrocytes. Osteoarthritis Cartilage 20:440-445
47. Roman-Blas JA, Jimenez SA 2006 NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 14:839-848
48. Zeold A, Doleschall M, Haffner MC, Capelo LP, Menyhert J, Liposits Z, da Silva WS, Bianco AC, Kacskovics I, Fekete C, Gereben B 2006 Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene. Endocrinology 147:4419-4429
49. Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, Harney JW, Larsen PR, Gross JL, Bianco AC, Maia AL 2005 The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90:3472-3478
50. Acosta BM, Bianco AC 2010 New insights into thyroid hormone replacement therapy. F1000 Med Rep 2:34
51. Larsen PR 2009 Type 2 iodothyronine deiodinase in human skeletal muscle: new insights into its physiological role and regulation. J Clin Endocrinol Metab 94:1893-1895
52. Zhu M, Tang D, Wu Q, Hao S, Chen M, Xie C, Rosier RN, O'Keefe RJ, Zuscik M, Chen D 2009 Activation of betacatenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res 24:12-21
53. Zhu M, Chen M, Zuscik M, Wu Q, Wang YJ, Rosier RN, O'Keefe RJ, Chen D 2008 Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum 58:2053-2064
54. Shen J, Li J, Wang B, Jin H, Wang M, Zhang Y, Yang Y, Im HJ, O'Keefe R, Chen D 2013 Deletion of the transforming growth factor beta receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum 65:3107-3119
55. Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, Askin FB, Frassica FJ, Chang W, Yao J, Carrino JA, Cosgarea A, Artemov D, Chen Q, Zhao Z, Zhou X, Riley L, Sponseller P, Wan M, Lu WW, Cao X 2013 Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19:704-712
56. Glasson SS, Blanchet TJ, Morris EA 2007 The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 15:1061-1069
57. Fonseca TL, Correa-Medina M, Campos MP, Wittmann G, Werneck-de-Castro JP, Arrojo E Drigo R, Mora-Garzon M, Ueta CB, Caicedo A, Fekete C, Gereben B, Lechan RM, Bianco AC 2013 Coordination of hypothalamic and pituitary T3 production regulates TSH expression. J Clin Invest 123:1492-1500
58. Henry SP, Jang CW, Deng JM, Zhang Z, Behringer RR, De Crombrugghe B 2009 Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage. Genesis 47:805-814